[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]
Fırat University Journal of Health Sciences (Veterinary)
2026, Cilt 40, Sayı 2, Sayfa(lar) 198-203
[ Özet ] [ PDF ] [ Benzer Makaleler ] [ Yazara E-Posta ] [ Editöre E-Posta ]
Sıçanlarda Klaritromisin Kaynaklı Hepatotoksiye Karşı C Vitamininin İyileştirici Etkisi: Oksidatif Stres, İnflamasyon, BAX/BCL-2/Kaspaz-3 ve Beklin-1/LC3A Yollarının Rolü
Ender ERDOĞAN1, Özge KANDEMİR2
1Atatürk University, Faculty of Veterinary Medicine, Department of Biochemistry, Erzurum, TÜRKİYE
2Aksaray University, Aksaray Technical Sciences Vocational School, Department of Food Processing, Aksaray, TÜRKİYE
Anahtar Kelimeler: Apoptoz, klaritromisin, hepatotoksisite, oksidatif stres, C vitamini
Özet
Bu çalışmanın amacı, sıçan karaciğerinde klaritromisin (CLM) uygulamasının toksik etkilerine karşı C vitamininin (Vit C) tedavi edici ve koruyucu etkilerini araştırmaktır. Çalışmada, sıçan karaciğerleri, karaciğer enzimleri, oksidatif stres, apoptoz, otofaji ve inflamasyon açısından incelenmiştir. CLM, 45 mg/kg dozda 7 gün boyunca oral yolla uygulandı. Vit C, 100 mg/kg/gün dozda intraperitoneal (i.p.) yol ile 7 gün boyunca uygulandı. Bulgular, Vit C'nin CLM uygulamasına yanıt olarak apoptoz belirteçlerini, oksidatif stresi, karaciğer enzimlerini, otofajik aktiviteyi ve inflamasyonu önemli ölçüde azalttığını göstermiştir. Sonuç olarak, hem insan hem de hayvan sağlığında yaygın olarak kullanılan CLM'nin karaciğer üzerindeki toksik etkilerine karşı Vit C'nin koruyucu etkisi gösterilmiştir.
  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Giriş
    Clarithromycin (CLM) is a broad-spectrum macrolide antibiotic developed in 1980 and approved for medical use in 1990. CLM is used in various bacterial infections such as streptococcal throat infection Lyme disease, pneumonia, Helicobacter pylori infection, and skin infections. The drug can be administered orally in tablet or liquid form or intravenously. CLM is a macrolide antibiotic. It exerts its effect by inhibiting the protein synthesis of bacteria 1. In addition to its common side effects, CLM has been reported to negatively affect the liver. Studies have shown that it increases liver enzymes and can lead to acute liver failure 2,3.

    Vit C is an essential water-soluble micronutrient with numerous effects, including maintaining redox balance, collagen biosynthesis, neurotransmitter formation, and immune defense 4. It is a very powerful antioxidant. It protects biomolecules from oxidative damage and contributes to enzymatic regulation and iron homeostasis 5. The recommended daily intake of Vit C for a healthy adult human is 500 mg 5. Previously, the effects of Vit C on organs such as the liver and kidneys were investigated, and it was shown to reduce oxidative stress, repair biochemical changes, and almost restore metabolic regulation 6,7.

    The main objective of this study is to investigate the liver-protective and preventive effects of Vit C against the toxic effects of CLM, a macrolide antibiotic widely used in human and animal health that has adverse effects on the liver.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Materyal ve Metot
    Research and Publication Ethics: Approval was obtained from the Necmettin Erbakan University Local Ethics Committee for Animal Experiments. Approval date and number: 27.11.2025, 2025-103. All experimental procedures in our study were carried out in accordance with European Directive 2010\63\AB. The study was carried out in accordance with ARRIVE guidelines.

    Chemicals: The drugs used in the study were CLM (Klamer®, 500 mg) from Atabay (İstanbul, Turkey) and Vit C (Maxivit-C®, 200 mg ascorbic acid per mL of 100 mL solution) from Arion (İstanbul, Turkey). The CLM dose was determined according to the methodology applied by Wen 8, while the Vit C dosage was established according to the study by Ayyıldız 9.

    Experimental Procedures: In this study, 28 Wistar albino rats were used. The rats weighed 225-255 g and were 11-13 weeks old. The rats were obtained from Necmettin Erbakan University KONUDAM Experimental Medicine Application and Research Center (Konya, Turkey). Rats were weighed, and four balanced groups were formed (n=7): 1. Control: A solution of normal saline was orally administered once daily for 7 days. 2. Clarithromycin (CLM): It was administered orally once daily for 7 days at a dose of 45 mg/kg, dissolved in 2 ml of distilled water. 3. Vit C (Vit C): It was administered once a day by i.p. route at a dose of 100 mg/kg/day for 7 days. 4. Clarithromycin+Vit C (CLM+Vit C): CLM administered orally once daily for 7 days at a dose of 45 mg/kg, dissolved in 2 mL of distilled water and Vit C was administered once a day by i.p. route at a dose of 100 mg/kg/day for 7 days. CLM administered first, followed Vit C treatment. CLM was administered orally to rats once daily for 7 days. Vit C was administered i.p. once daily for 7 days. The experiment was terminated on day 8. The procedures and substance administrations were carried out according to predetermined protocols 8,9. The rats used in the experiment were sacrificed by decapitation under sevoflurane anesthesia (100% Sevorane fluid) 24 h after their last treatment. Blood samples were collected in tubes without anticoagulant and centrifuged at 3000 xg for 10 minutes at 4ºC to extract the serum, which was then separated for ALT and AST determination. The livers were rapidly removed from the animals and stored at -80°C for biochemical analysis.

    Liver Function Tests: To assess hepatic function, serum levels of AST and ALT were measured. All analyses were carried out using commercial assay kits, following the manufacturer's instructions. Serum samples obtained from blood were prepared in the laboratory under necessary precautions, and enzyme activities were measured using spectrophotometric methods.

    Lipid Peroxidation and Antioxidant Analyses in Liver Tissue: Liver tissue was homogenized in 1.15% potassium chloride solution in a homogenizer (TissueLyser II, Qiagen, Netherlands) to obtain homogenate. The protein content of liver tissue was evaluated using the methods of Lowry et al. 10, malondialdehyde (MDA) level by Placer et al. 11, glutathione (GSH) level by Sedlak and Lindsay 12, catalase (CAT) activity by Aebi 13, superoxide dismutase (SOD) activity by Sun et al. 14, and glutathione peroxidase (GPx) activity by Lawrence and Burk 15.

    Real Time – Polymerase Chain Reaction (RT-PCR): RNA was obtained from rat liver tissues. (QlAzol Lysis Reagent 79306, QIAGEN) cDNA was synthesized from the RNA samples (OneScript Plus cDNA Synthesis Kit, ABM, G236, Richmond, Canada). The obtained cDNA was used to determine the mRNA levels of cysteine-aspartic protease-3 (Caspase-3), BCL2 Associated X (Bax), B-cell lymphoma 2 (Bcl-2), nuclear factor kappa B (NF-κB) and interleukin 1 beta (IL-1β), Beclin 1, Light Chain 3 Alpha (LC3A) genes. The primer sequences are given in Table 1 16 using the 2^−ΔΔCT method, normalized to β-Actin 17.


    Büyütmek İçin Tıklayın
    Table 1: Primer sequences

    Statistical Analysis: SPSS 26.0 software was used to analyze the data obtained in the study (SPSS Inc., Chicago, USA). Shapiro-Wilk and Kolmogorov-Smirnov normality tests and QQ plots were used to assess the distribution of variables. Homogeneity of variance was assessed using Brown-Forsythe and Bartlett tests. For data satisfying the assumptions of normal distribution and homogeneity of variance, one-way analysis of variance (One-Way ANOVA) and Tukey multiple comparison test were used. Statistically significant data are presented as mean ± standard deviation (SD). Differences were considered statistically significant at the p<0.05, p<0.01, and p<0.001 levels.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Bulgular
    Results of Liver Function Test: Compared to the control group, CLM administration increased ALT and AST levels (p<0.001). Compared to the CLM group, CLM+Vit C supplementation resulted in a significant decrease in both ALT (p<0.01) and AST (p<0.001) values. Compared to the control group, the difference in CLM+Vit C administered group was highly statistically significant (p<0.001). In conclusion, Vit C treatment reduced the negative effects of CLM (Figure 1).


    Büyütmek İçin Tıklayın
    Figure 1: Effects of clarithromycin (CLM) and Vit C (Vit C) applications on aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in rat liver tissue. Values are given as mean ± standard deviation. Statistical signifcance (ns: not significant, *p<0.05, **p<0.01, ***p<0.001).

    Effects of CLM and Vit C on Lipid peroxidation and Activity of Antioxidants in Liver Tissues: When the CLM-treated group was compared with the Control Group, a significant increase in MDA levels was observed. Simultaneously, a decrease was observed in antioxidant GPx, SOD, GSH, and CAT activities (p<0.001). On the other hand, when the CLM+Vit C group was compared with the CLM group, a significant decrease in MDA levels was observed (p<0.001), while a significant increase was observed in CAT, SOD, GPx, and GSH levels (p<0.001). Compared to the control group, CLM+Vit C administered MDA levels increased significantly (p<0.001), while GSH, GPx, SOD, and CAT levels decreased significantly (p<0.001) (Figure 2).


    Büyütmek İçin Tıklayın
    Figure 2: Effects of clarithromycin (CLM) and Vit C (Vit C) administrations on malondialdehyde (MDA) and glutathione (GSH) levels and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activity in liver tissue of rats. Values are given as mean ± standard deviation. Statistical signifcance (ns: not significant, *p<0.05, **p<0.01, ***p<0.001).

    Inflammatory Parameters in Liver Tissue: NF-κB and IL-1β parameters were examined to measure the degree of inflammation. NF-κB and IL-1β levels were higher in the CLM-treated group compared to the control group (p<0.001). The group administered with CLM + Vit C showed lower levels of NF-κB and IL-1β compared to the CLM group (p<0.01). Compared to the control group, CLM+Vit C administered NF-κB and IL-1β were significantly higher (p<0.001) (Figure 3).


    Büyütmek İçin Tıklayın
    Figure 3: Effects of clarithromycin (CLM) and Vit C (Vit C) applications on nuclear factor kappa B (NF-κB) and interleukin 1 beta (IL-1β) levels in rat liver tissue. Values are given as mean ± standard deviation. (ns: not significant, *p<0.05, **p<0.01, ***p<0.001).

    Apoptosis in Liver Tissue: To determine apoptotic damage, Caspase-3, Bax, and BCL-2 levels were examined in liver tissues. RT-PCR was used to analyze mRNA transcription levels. In the CLM group, compared to the CLM+Vit C group, an increase in apoptotic Caspase-3 and Bax levels was observed (p<0.001), while a significant decrease in anti-apoptotic Bcl-2 levels was observed (p<0.05). Compared to the control group, the group treated with CLM+Vit C had higher levels of Caspase-3 (p<0.001) and Bax (p<0.01) and lower level of Bcl-2 (p<0.01) (Figure 4).


    Büyütmek İçin Tıklayın
    Figure 4: Effects of clarithromycin (CLM) and Vit C (Vit C) administrations on cysteine-aspartic proteases-3 (Caspase-3), BCL2 associated X (Bax) and B-cell lymphoma 2 (Bcl-2) mRNA transcription levels in liver tissue of rats. Values are given as mean ± standard deviation. Statistical signifcance (ns: not significant, *p<0.05, **p< 0.01, ***p<0.001).

    Autophagy: Beclin-1 and Light chain 3 alpha (LC3A) markers were measured to assess autophagic damage. mRNA levels were determined by RT-PCR. In the CLM group, autophagic markers increased compared to the control group (p<0.001). In the CLM+Vit C group, autophagic activity showed a significant decrease in both markers compared to the CLM group (p<0.01 and p<0.05, respectively). Compared to the control group, the group treated with CLM+Vit C had significantly higher levels of Beclin-1 and LC3A (p<0.001) (Figure 5).


    Büyütmek İçin Tıklayın
    Figure 5: Effects of clarithromycin (CLM) and Vit C (Vit C) administrations on Beclin-1 and Light Chain 3 Alpha (LC3A) mRNA transcription levels in liver tissue of rats. Values are given as mean ± standard deviation. Statistical signifcance (ns: not significant, *p<0.05, **p<0.01, ***p<0.001).

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Tartışma
    According to the results of the study, Vit C treatment mitigated existing liver damage caused by CLM application by regulating elevated liver enzymes, oxidative stress, apoptosis, and autophagy damage pathways.

    Free radicals cause oxidative stress, which can lead to tissue damage 18,19. Increasing the production of reactive oxygen species (ROS) increases the oxidant capacity in parallel 20. Conversely, antioxidants found in the cell can neutralize free radicals, thus keeping ROS levels in balance 21,22. Consequently, if the antioxidant capacity decreases while the ROS level increases in the cell, oxidative stress is triggered 23,24. When oxidative stress occurs, it can damage the cell's lipid structure, protein content, and DNA 25. Lipids in the cell membrane are directly affected by increased ROS, and MDA levels increase simultaneously 26. Among antioxidant enzymes, SOD converts superoxide, an oxidative stress product, into hydrogen peroxide (H2O2). CAT breaks down H2O2 into oxygen and water, while GPx is effective in neutralizing both cytotoxic lipid peroxides and H2O2. The non-enzymatic antioxidant GSH reduces high ROS levels 27,28. It has been observed that CLM application increases MDA level, decreases CAT, GPx, SOD, and GSH levels, and consequently increases oxidative stress 29. Vit C, on the other hand, has the opposite effect, reducing oxidative stress.

    Increased ROS levels increase NF-κB, which triggers inflammation, and IL-1β, a cytokine that NF-κB stimulates 30,31. Therefore, lowering NF-κB and the inflammatory cytokines it stimulates, L-1β and IL-6 levels, can reduce the inflammatory process 32. In this study, evaluated using rat liver, CLM administration increased NF-κB and IL-1β levels in tissues and increased inflammatory damage. Vit C, on the other hand, reduced all these effects of CLM.

    Apoptosis is programmed cell death 33. Apoptosis typically occurs in healthy cells following cellular stress or injury 16. It is effective in removing cells damaged by increased free radical production and thus from the environment, and this occurs through the activation of caspases 34. P53, which plays a critical role in cell death caused by DNA damage, increases over time when DNA is damaged, phosphorylation occurs, and excessive proapoptotic reactions are triggered 35. The mitochondrial pathway plays a critical role in apoptosis processes. When the level of Bax, a pro-apoptotic protein, exceeds the levels of anti-apoptotic proteins, Bax translocates to the cytoplasm, thereby triggering apoptotic caspase activation 36,37. This study showed that CLM administration caused damage to rat liver tissues by increasing apoptotic factors and decreasing anti-apoptotic factors. CLM+Vit C administration reversed this situation. Vit C treatment showed protective properties against apoptotic damage caused by CLM administration in liver tissues.

    Autophagy is a cell-to-cell degradation process induced by Beclin-1 and LC3A, involving the breakdown of unnecessary or damaged organelles and proteins within cells via lysosomes 38. Autophagy is also induced by oxidative stress 39. An excessive increase in autophagy levels causes tissues and organs to lose their function 40. Therefore, autophagy plays a crucial role in adaptation and cellular immunity 41. Vit C, on the other hand, has shown protective properties against autophagic damage by reducing CLM-derived LC3A and Beclin 1 levels 42. The CLM application triggers autophagy by increasing the amount of free Beclin-1 through phosphorylated Bcl-2. This, in turn, causes CLM to influence autophagy as a "damaging process" 43.

    The liver is a vital organ with a crucial function: removing toxic substances from the body 44. AST and ALT enzymes are liver biomarkers. High levels indicate both disruption of the integrity of the cell membranes of liver tissue and liver damage. Increased serum AST and ALT enzyme levels occur as a result of the leakage of these enzymes into the blood due to the disruption of membrane integrity following damage or necrosis of hepatocytes 24. In the present study, increased serum AST and ALT levels with CLM administration indicate that CLM causes toxic damage to liver tissue. A decrease in serum AST and ALT levels was observed with CLM+Vit C administration. Thus, Vit C administration had a protective effect against the toxic effects of CLM on the liver.

    This study presents clinically significant potential for Vit C treatment in CLM-induced hepatotoxicity. Pathological processes caused by CLM led to severe damage in rat liver. Vit C administration mitigated these negative changes 45. In medical practice, the application of Vit C in the treatment of serious damages such as hepatotoxicity stands out as an effective method that accelerates tissue healing by reducing oxidative stress, inflammation, and apoptosis. Our study has demonstrated the supportive effects of Vit C on tissue healing through its protective effects on cellular proliferation, apoptotic damage, and inflammation 26. The findings of the study suggest that Vit C can be incorporated into medical treatment protocols and may be an adjunct treatment option, particularly in acute conditions such as liver damage.

    Consequently, based on the findings of the current study, it was observed that CLM causes toxic damage in rat liver tissues by activating oxidative stress, apoptosis, inflammation, and autophagic damage pathways. In contrast, Vit C treatment showed protective properties against CLM toxic damage by reducing the effects of all these damage pathways. Vitamin C achieved this protective effect by maintaining the Bax/Bcl-2 balance.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • Kaynaklar

    1) Sodeifian G, Bagheri H, Nooshabadi MA, et al. Comprehensive solubility analysis of clarithromycin drug in SC-CO2: Experimental data and evaluation of multiple theoretical and semi-empirical models J Supercrit Fluids 2026: 106967.rn

    2) Brown BA, Wallace Jr RJ, Griffith DE, Girard W. Clarithromycin-induced hepatotoxicity. Clin Infect Dis 1995; 20: 1073-1074.rn

    3) Edhi AI, Hakim S, Shams C, et al. Clarithromycin‐associated acute liver failure leading to fatal, massive upper gastrointestinal hemorrhage from profound coagulopathy: Case report and systematic literature review. Case Rep Hepatol 2020; 2020: 2135239.rn

    4) Yan B, Davachi SM, Ravanfar R, et al. Improvement of vitamin C stability in vitamin gummies by encapsulation in casein gel. Food Hydrocoll 2021; 113: 106414.rn

    5) Amalraj A, Abraham EK, Nair AS, Sivarajakumar P, Gopi S. Development of Highly Stable Vitamin C Gummies using Innovative in Situ Soft Sphere Integrated (ISSI) Liposomal Technology: Characterization and in vitro Release Studies. ACS Omega 2026.rn

    6) Poli V, Aparna Y, Madduru R, Motireddy SR. Protective effect of Vitamin C and E on enzymatic and antioxidant system in liver and kidney toxicity of Cadmium in rats. Appl Food Res 2022; 2: 100098.rn

    7) Erdoğan E, Kandemir Ö, Akaras N, Şimşek H, Kandemir FM. Investigation of the protective and preventive effect of vitamin C against the toxic effect of dexketoprofen trometamol on rat kidney. Harran Univ J Fac Vet Med 2025; 14: 217-225.rn

    8) Wen J, ChenYang, Zhao M, Hu W, Xiao YW. Effects of clarithromycin on the pharmacokinetics of tacrolimus and expression of CYP3A4 and P‐glycoprotein in rats. Fundam Clin Pharmacol 2023; 37: 843-848.rn

    9) Ayyildiz M, Coskun S, Yildirim M, Agar E. The effects of ascorbic acid on penicillin‐induced epileptiform activity in rats. Epilepsia 2007; 48: 1388-1395.rn

    10) Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. 1951.rn

    11) Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyldialdehyde) in biochemical systems. Anal Biochem 1966; 16: 359-364.rn

    12) Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.rn

    13) Aebi H. Catalase in vitro. Methods Enzymol 105: Elsevier; 1984: 121-126.rn

    14) Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.rn

    15) Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976; 71: 952-958.rn

    16) Akcılar R, Akçer S, Şimşek H, Akcılar A, Bayat Z, Genç O. The effect of ozone on blood pressure in DOCA-salt-induced hypertensive rats. Int J Clin Exp Med 2015; 8: 12783.rn

    17) Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 2001; 25: 402-408.rn

    18) Yardim A, Gur C, Comakli S, et al. Investigation of the effects of berberine on bortezomib-induced sciatic nerve and spinal cord damage in rats through pathways involved in oxidative stress and neuro-inflammation. Neurotoxicology 2022; 89: 127-139.rn

    19) Kandemir Ö, Küçükler S, Özdemir S, et al. Protective effects of quercetin against vincristine‐induced nephrotoxicity via modulation of oxidative stress, inflammation, and apoptosis in rats. J Biochem Mol Toxicol 2025; 39: e70516.rn

    20) Gur C, Kandemir FM. Molecular and biochemical investigation of the protective effects of rutin against liver and kidney toxicity caused by malathion administration in a rat model. Environ Toxicol 2023; 38: 555-565.rn

    21) Aksu EH, Kandemir FM, Küçükler S. The effects of hesperidin on colistin‐induced reproductive damage, autophagy, and apoptosis by reducing oxidative stress. Andrologia 2021; 53: e13900.rn

    22) Ekinci Akdemir FN, Yildirim S, Kandemir FM, et al. Protective effects of baicalein and bergenin against gentamicin‐induced hepatic and renal injuries in rats: An immunohistochemical and biochemical study. Basic Clin Pharmacol Toxicol 2025; 136: e14121.rn

    23) Öz MA, Kandemir Ö, Özdemir S, et al. Chrysin attenuates tramadol-driven renal dysfunction via regulation of RNA networks, antioxidant pathways, and ketogenic metabolism. Eur J Pharmacol 2026: 178882.rn

    24) Ekinci Akdemir FN, Yildirim S, Kandemir FM, et al. Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study. Arch Physiol Biochem 2021; 127: 258-265.rn

    25) Özdemir S, Kucukler S, Çomaklı S, Kandemir FM. The protective effect of morin against ifosfamide-induced acute liver injury in rats associated with the inhibition of DNA damage and apoptosis. Drug Chem Toxicol 2022; 45: 1308-1317.rn

    26) Kandemir Ö, Kandemir FM, Küçükler S, et al. Chrysin as a therapeutic adjunct to prevent ısoniazid-induced nephrotoxicity in rats: Biochemical, molecular, and histopathological evidence. Tissue Cell 2026: 103527.rn

    27) Aktas MS, Kandemir FM, Kirbas A, Hanedan B, Aydin MA. Evaluation of oxidative stress in sheep infected with Psoroptes ovis using total antioxidant capacity, total oxidant status, and malondialdehyde level. J Vet Res 2017; 61: 197.rn

    28) Erişir M, Benzer F, Kandemir FM. Changes in the rate of lipid peroxidation in plasma and selected blood antioxidants before and during pregnancy in ewes. Acta Vet Brno 2009; 78: 237-242.rn

    29) Erdoğan E, Kandemir Ö, Akaras N, Şimşek H, Kandemir FM. Protective and preventive role of folic acid against ivermectin-ınduced renal toxicity. Firat Univ Saglik Bilim Vet Derg 2025; 39.rn

    30) Caglayan C, Kandemir FM, Ayna A, et al. Neuroprotective effects of 18β-glycyrrhetinic acid against bisphenol A-induced neurotoxicity in rats: Involvement of neuronal apoptosis, endoplasmic reticulum stress and JAK1/STAT1 signaling pathway. Metab Brain Dis 2022; 37: 1931-1940.rn

    31) Gur C, Kandemir O, Kandemir FM. Investigation of the effects of hesperidin administration on abamectin‐induced testicular toxicity in rats through oxidative stress, endoplasmic reticulum stress, inflammation, apoptosis, autophagy, and JAK2/STAT3 pathways. Environ Toxicol 2022; 37: 401-412.rn

    32) Şimşek H, Küçükler S, Gür C, Akaras N, Kandemir FM. Protective effects of sinapic acid against lead acetate-induced nephrotoxicity: A multi-biomarker approach. Environ Sci Pollut Res 2023; 30: 101208-101222.rn

    33) Güçlü A, Erken HA, Erken G, et al. The effects of ozone therapy on caspase pathways, TNF-α, and HIF-1α in diabetic nephropathy. Int Urol Nephrol 2016; 48: 441-450.rn

    34) Şimşek H, Demiryürek Ş, Demir T, et al. Assessment of expressions of Bcl-XL, b-FGF, Bmp-2, Caspase-3, PDGFR-α, Smad1 and TGF-β1 genes in a rat model of lung ischemia/reperfusion. Iran J Basic Med Sci 2016; 19: 209.rn

    35) Aydin M, Cevik A, Kandemir F, Yuksel M, Apaydin A. Evaluation of hormonal change, biochemical parameters, and histopathological status of uterus in rats exposed to 50-Hz electromagnetic field. Toxicol Ind Health 2009; 25: 153-158.rn

    36) Küçükler S, Kandemir FM, Özdemir S, Çomaklı S, Caglayan C. Protective effects of rutin against deltamethrin-induced hepatotoxicity and nephrotoxicity in rats via regulation of oxidative stress, inflammation, and apoptosis. Environ Sci Pollut Res 2021; 28: 62975-62990.rn

    37) Çelik H, Kucukler S, Çomaklı S, et al. Neuroprotective effect of chrysin on isoniazid-induced neurotoxicity via suppression of oxidative stress, inflammation and apoptosis in rats. Neurotoxicology 2020; 81: 197-208.rn

    38) Aygörmez S, Makav M, Kuru M, et al. The ameliorative effects of morin on colistin‐ınduced kidney injury in ovariectomized rats: Reduces oxidative stress, inflammation damage, apoptosis, and autophagic death. J Biochem Mol Toxicol 2025; 39: e70592.rn

    39) Öz MA, Şimşek H, Özdemir S, et al. Sinapic acid attenuates colistin-driven nephrotoxicity by targeting the miRNA-21/SIRT1/NF-κB pathway and facilitating tubular repair and inflammation in a rat model. Toxicol Appl Pharmacol 2026: 117708.rn

    40) Akay M, Küçükler S, Özdemir S, et al. Rutin attenuates colistin-induced nephrotoxicity through modulation of inflammation, oxidative stress, and miRNA-Associated pathways: An experimental study. Food Biosci 2026; 78: 108527.rn

    41) Bülbül R, Küçükler S, Çomaklı S, et al. Protective effects of polydatin on cyclophosphamide-ınduced ovarian and uterine damage in rats via modulation of hormonal, oxidative, inflammatory, and histopathological alterations. Tissue Cell 2026: 103309.rn

    42) Öz MA, Şimşek H, Özdemir S, et al. Nephroprotective effects of vanillic acid on bortezomib‐induced renal injury: Role of oxidative stress, mitochondrial dysfunction, apoptosis and miR‐204 / nephrin / podocin / CD2AP axis. Basic Clin Pharmacol Toxicol 2026; 138: e70223.rn

    43) Park WY, Lim S-H, Kim Y, et al. Impact of ciprofloxacin with autophagy on renal tubular injury. Medicine 2024; 103: e39888.rn

    44) Aygörmez S, Küçükler S, Çomaklı S, et al. Protective role of polydatin against vancomycin‐induced lung toxicity via oxidative stress, inflammation, endoplasmic reticulum stress, apoptosis, and ferroptosis pathways. J Appl Toxicol 2026.rn

    45) Aksu EH, Kandemir FM, Küçükler S. Ameliorative effect of hesperidin on streptozotocin‐diabetes mellitus‐induced testicular DNA damage and sperm quality degradation in Sprague–Dawley rats. J Food Biochem 2021; 45:e13938.

  • Başa Dön
  • Özet
  • Giriş
  • Materyal ve Metot
  • Bulgular
  • Tartışma
  • Kaynaklar
  • [ Başa Dön ] [ Özet ] [ PDF ] [ Benzer Makaleler ] [ Yazara E-Posta ] [ Editöre E-Posta ]
    [ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]